Wed Sep 25 07:54:54 UTC 2024: ## NovaBay Pharmaceuticals Stock Surges Above 50-Day Moving Average

**New York, NY (MarketBeat News) -** NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN: NBY) saw its stock price rise above its 50-day moving average on Tuesday, closing at $0.71. This upward movement comes after the company reported a quarterly earnings loss of $1.37 per share on August 13th, despite generating revenue of $2.40 million.

The biopharmaceutical company, which develops and sells eye care and wound care products, has a market capitalization of $2.97 million, a price-to-earnings ratio of -0.07, and a beta of 2.82. Analysts are expecting NovaBay Pharmaceuticals to post a loss of $2.54 per share for the current year.

NovaBay Pharmaceuticals’ product portfolio includes Avenova Spray, Avenova Eye Health Support supplements, Avenova Lubricating Eye Drops, NovaWipes by Avenova, Avenova WarmEye Compress, and the i-Chek by Avenova. The company operates both domestically and internationally.

**Disclaimer:** This news article is based on information provided by MarketBeat News and does not constitute financial advice.

Read More